Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,560.00    60.00 (1.09%)
Bid:
5,560.00
Ask:
5,570.00
Spread: 10.00 (0.18%)
Market Cap: £2.98b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

First Half Trading Statement

6 Oct 2014 07:00

RNS Number : 4631T
Cranswick PLC
06 October 2014
 

 

6 October 2014

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

First half trading statement

 

Cranswick, the UK food producer, today provides an update on trading for the six months ended 30 September 2014.

 

First half performance

 

Trading during the first half of the year has been in line with the Board's expectations.

 

Revenue in the six months ended 30 September 2014 was in line with the same period last year. Growth across most product categories offset lower sales of fresh pork and, as planned, a greater proportion of the Group's own pigs were utilised internally.

 

The markets in which the Group operates continue to be competitive. Operating margins# in the first half are expected to be similar to those achieved in the previous financial year as a whole reflecting the Group's continued focus on operating efficiencies, product quality and innovation. Pig prices eased during the second quarter of the financial year and are now below the record highs seen at this time last year.

 

During the period, the Group has invested further in its asset base to increase capacity and improve efficiency. Work to extend the Delico cooked meats facility in Milton Keynes was completed on time and to budget. The project provides more capacity to meet anticipated sales growth and the investment in advanced cooking and slicing technology will deliver increased throughput and enhanced yields. A major upgrade to the chilling system at the Norfolk primary processing facility, which is nearing completion, will deliver similar benefits.

 

Financial position

 

Net borrowings were down on the previous quarter end and well below those of a year ago, notwithstanding the on-going capital investment programme across the business. The Group is in a sound financial position with committed, unsecured facilities of £120 million, which provide generous headroom going forward.

 

Outlook

 

Cranswick continues to work closely with its customers and maintain its focus on service, quality and innovation to deliver exciting, competitively priced products. This approach, allied to a growing export trade, a broadening product portfolio and an increasing demand for premium British pork products by the UK consumer, leaves the business well-placed to deliver further growth.

 

With experienced management at all levels of the Group, a strong range of products, a well-invested asset base and a robust financial position, the Board remains confident in the continued long term success and development of the business.

 

Market conditions through the second half of the year are expected to remain competitive, however with a strong Christmas trading period anticipated in the third quarter of the financial year, the Group is well placed to deliver a full year performance that is in line with the Board's expectations.

 

The Company intends to announce its interim results on 24 November 2014.

 

 

Enquiries:

 

Cranswick plc

01482 372 000

Mark Bottomley, Finance Director

Powerscourt

020 7250 1446

Nick Dibden / Sophie Moate

 

Notes:

1. Cranswick's activities are focused within the UK and include the processing and supply of fresh pork, sausage, bacon, cooked meats, charcuterie, pastry products and sandwiches. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2014 showed revenues of £995m and profit before tax of £54.8m.

2. This announcement is based on information sourced from unaudited management accounts.

3. This announcement contains certain forward looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements. Nothing in this announcement should be construed as a profit forecast.

 

# excluding net IAS 41 valuation movement on biological assets in the current and prior financial years and non-recurring items in the prior financial year

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUOANRSAARRAA
Date   Source Headline
20th May 202112:03 pmRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSChange of Chairmanship
18th May 20217:00 amRNSPreliminary Results
4th May 20213:56 pmRNSTotal Voting Rights
1st Apr 20213:32 pmRNSBlock listing Interim Review
1st Apr 20213:31 pmRNSBlock listing Interim Review
1st Apr 20213:29 pmRNSTotal Voting Rights
26th Mar 20219:48 amRNSDirector/PDMR Shareholding
26th Mar 20219:48 amRNSDirector/PDMR Shareholding
26th Mar 20219:47 amRNSDirector/PDMR Shareholding
23rd Mar 20216:03 pmRNSHolding(s) in Company
23rd Mar 20219:07 amRNSDirector/PDMR Shareholding
23rd Mar 20219:06 amRNSDirector/PDMR Shareholding
16th Mar 20211:29 pmRNSDirector/PDMR Shareholding
16th Mar 20218:30 amRNSNon-Executive Director Appointment
2nd Mar 20217:30 amRNSDirector/PDMR Shareholding
15th Feb 20212:59 pmRNSDirector/PDMR Shareholding
4th Feb 20217:00 amRNSThird Quarter Trading Statement
1st Feb 202110:29 amRNSTotal Voting Rights
28th Jan 20213:01 pmRNSAdditional Listing
28th Jan 20217:44 amRNSAdditional Listing
25th Jan 202112:31 pmRNSDirectorship
13th Jan 20218:38 amRNSHolding(s) in Company
4th Jan 20212:19 pmRNSTotal Voting Rights
24th Dec 20207:51 amRNSHolding(s) in Company
24th Dec 20207:49 amRNSDividend Announcement
17th Dec 20207:00 amRNSWithdrawal from Acquisition Process
16th Dec 202011:22 amRNSResponse to Press Speculation
11th Dec 20208:39 amRNSHolding(s) in Company
1st Dec 20208:26 amRNSTotal Voting Rights
24th Nov 20203:45 pmRNSHolding(s) in Company
24th Nov 20207:00 amRNSInterim Results
18th Nov 20204:37 pmRNSHolding(s) in Company
3rd Nov 20205:15 pmRNSTotal Voting Rights
27th Oct 20202:55 pmRNSHolding(s) in Company
27th Oct 20202:51 pmRNSHolding(s) in Company
26th Oct 202011:51 amRNSHolding(s) in Company
1st Oct 20201:54 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 20201:51 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 20201:49 pmRNSTotal Voting Rights
25th Sep 20202:34 pmRNSHolding(s) in Company
2nd Sep 20202:01 pmRNSAdditional Listing
1st Sep 202011:45 amRNSDirector/PDMR Shareholding
1st Sep 202011:18 amRNSTotal Voting Rights
17th Aug 20202:57 pmRNSPoll Result for 2020 Annual General Meeting
17th Aug 20207:00 amRNSFirst quarter trading statement
11th Aug 20207:00 amRNSAnnual General Meeting update
3rd Aug 20202:30 pmRNSTotal Voting Rights
31st Jul 202012:26 pmRNSDirector/PDMR Shareholding
31st Jul 202012:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.